Stocktoria

Ultragenyx Pharmaceutical Inc. RARE

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-01-31 · LEI

Ultragenyx Pharmaceutical Inc. statistics & valuation

Market cap$3.0B
P / S4.5×
Net margin-85.4%
FCF margin-70.1%
Return on capital-46.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-184867.70% -11567.30% -383.70% -388.30% -68.80% -129.20% -194.70% -139.90% -101.60% -85.40% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-186471.40% -12593.50% -721.20% -409.00% -121.80% -108.60% -178.60% -131.10% -95.70% -79.50% 2016201720182019202020212022202320242025
Return on equity (%)
-51.90% -78.80% -32.50% -61.60% -16.20% -49.20% -201.00% -220.70% -223.10% 2016201720182019202020212022202320242025
Shares outstanding
41.2M 44.2M 50.9M 57.8M 66.8M 69.3M 70.2M 82.3M 92.5M 98.6M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-45.50% -61.60% -27.50% -35.50% -10.60% -29.80% -45.80% -40.70% -37.90% -37.50% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-128694.00% -9825.30% -572.20% -357.00% -65.00% -117.20% -136.70% -119.60% -75.20% -70.10% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$3.07 -$6.70 -$10.12 -$8.25 -$6.29 -$5.83 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-79.5%-95.7%-131.1%-178.6%-108.6%-121.8%-409.0%-721.2%-12593.5%-186471.4%
Net margin-85.4%-101.6%-139.9%-194.7%-129.2%-68.8%-388.3%-383.7%-11567.3%-184867.7%
FCF margin-70.1%-75.2%-119.6%-136.7%-117.2%-65.0%-357.0%-572.2%-9825.3%-128694.0%
Return on assets-37.5%-37.9%-40.7%-45.8%-29.8%-10.6%-35.5%-27.5%-61.6%-45.5%
Return on equity718.8%-223.1%-220.7%-201.0%-49.2%-16.2%-61.6%-32.5%-78.8%-51.9%
Current ratio2.482.382.613.384.726.838.246.993.806.67

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.